Skip to main content

Patient preferences for targeted agents in renal cell carcinoma (RCC): A benefit–risk conjoint study.

Publication ,  Journal Article
Hauber, AB; Mohamed, AF; Johnson, FR; Neary, M
Published in: Journal of Clinical Oncology
May 20, 2010

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2010

Volume

28

Issue

15_suppl

Start / End Page

4596 / 4596

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hauber, A. B., Mohamed, A. F., Johnson, F. R., & Neary, M. (2010). Patient preferences for targeted agents in renal cell carcinoma (RCC): A benefit–risk conjoint study. Journal of Clinical Oncology, 28(15_suppl), 4596–4596. https://doi.org/10.1200/jco.2010.28.15_suppl.4596
Hauber, A. B., A. F. Mohamed, F. R. Johnson, and M. Neary. “Patient preferences for targeted agents in renal cell carcinoma (RCC): A benefit–risk conjoint study.Journal of Clinical Oncology 28, no. 15_suppl (May 20, 2010): 4596–4596. https://doi.org/10.1200/jco.2010.28.15_suppl.4596.
Hauber AB, Mohamed AF, Johnson FR, Neary M. Patient preferences for targeted agents in renal cell carcinoma (RCC): A benefit–risk conjoint study. Journal of Clinical Oncology. 2010 May 20;28(15_suppl):4596–4596.
Hauber, A. B., et al. “Patient preferences for targeted agents in renal cell carcinoma (RCC): A benefit–risk conjoint study.Journal of Clinical Oncology, vol. 28, no. 15_suppl, American Society of Clinical Oncology (ASCO), May 2010, pp. 4596–4596. Crossref, doi:10.1200/jco.2010.28.15_suppl.4596.
Hauber AB, Mohamed AF, Johnson FR, Neary M. Patient preferences for targeted agents in renal cell carcinoma (RCC): A benefit–risk conjoint study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010 May 20;28(15_suppl):4596–4596.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2010

Volume

28

Issue

15_suppl

Start / End Page

4596 / 4596

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences